Adverse Reactions Associated with Skin Testing and Immunotherapy
Abstract:Fatalities have been associated with allergen skin testing and immunotherapy. Therefore, physicians using such tests and therapy should be knowledgeable in their use and take proper precautions to decrease the risk of anaphylaxis. The American Academy of Allergy and Immunology recommends a 20-minute wait that can be extended for high risk patients following an injection, and that the physician in charge of administering immunotherapy should be familiar with and prepared to appropriately treat anaphylaxis. Future treatment with peptides rather than whole allergens may increase safety.
Document Type: Research Article
Publication date: 1995-11-01
More about this publication?
- Allergy and Asthma Proceedings is a peer reviewed publication dedicated to distributing timely scientific research regarding advancements in the knowledge and practice of allergy, asthma and immunology. Its primary readership consists of allergists and pulmonologists.
The goal of the Proceedings is to publish articles with a predominantly clinical focus which directly impact quality of care for patients with allergic disease and asthma.
Featured topics include asthma, rhinitis, sinusitis, food allergies, allergic skin diseases, diagnostic techniques, allergens, and treatment modalities. Published material includes peer-reviewed original research, clinical trials and review articles.
Articles marked "F" offer free full text for personal noncommercial use only.
The journal is indexed in Thomson Reuters Web of Science and Science Citation Index Expanded, plus the National Library of Medicine's PubMed service.
- Editorial Board
- Information for Authors
- Submit a Paper
- Information for Advertisers
- Reprint Requests
- Ingenta Connect is not responsible for the content or availability of external websites